P2RX4 and myeloid sarcoma: This study used exome sequencing data from the British Columbia patient cohort and a family with multiple affected members to investigate related candidate genes: The purinergic receptors P2RX7 and P2RX4 are transmembrane cation channels known to be important in the pro-inflammatory cascade, and have previously been shown to modulate MS susceptibility.